LifeStance Health Group, Inc.

Total Valuation

LifeStance Health Group, Inc. carries a market capitalization of 4.94B, placing it among publicly traded companies globally. Its enterprise value stands at 4.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

LifeStance Health Group, Inc. currently has 382.02M shares outstanding.

Valuation Ratios

LifeStance Health Group, Inc. trades at a trailing price-to-earnings ratio of 81.68. The price-to-sales ratio is 2.61, and the price-to-book ratio stands at 2.77.

Enterprise Valuation

On an enterprise value basis, LifeStance Health Group, Inc. trades at an EV/EBITDA multiple of 32.52 and an EV/FCF ratio of 16.05. The EV/Sales ratio of 2.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 55.15 provides insight into valuation relative to core operating earnings.

Financial Position

LifeStance Health Group, Inc. maintains a current ratio of 1.38, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.12, indicating elevated leverage, while an interest coverage ratio of 13.15 demonstrates strong ability to service its debt obligations.

Financial Efficiency

LifeStance Health Group, Inc. posts a return on equity of 3.43 and a return on invested capital of 3.06.

Taxes

Over the trailing twelve months, LifeStance Health Group, Inc. has paid 16.39M in income taxes, reflecting an effective tax rate of 24.47.

Stock Price Statistics

LifeStance Health Group, Inc.'s stock has gained approximately 132.72395% over the past 52 weeks. The 50-day moving average sits at 11.41, while the 200-day moving average is 8.20.

Income Statement

Over the trailing twelve months, LifeStance Health Group, Inc. generated 1.58B in revenue and converted that into 50.60M in net income, yielding earnings per share of 0.13. EBITDA reached 132.99M, while operating income came in at 78.43M.

Balance Sheet

LifeStance Health Group, Inc. holds 225.94M in cash and equivalents against 459.65M in total debt, resulting in a net debt position of 33.05M. Total book value stands at 1.48B, with working capital of 103.21M providing operational flexibility.

Cash Flow

LifeStance Health Group, Inc. produced 217.87M in operating cash flow over the past twelve months. After subtracting -43.96M in capital expenditures, free cash flow totaled 173.91M - equivalent to 0.45 per share.

Margins

LifeStance Health Group, Inc. operates with a gross margin of 33.56, reflecting its pricing power and cost economics. The operating margin of 4.95 and net profit margin of 3.19 provide insight into operational efficiency.

Dividends & Yields

Scores

LifeStance Health Group, Inc. posts an Altman Z-Score of 4.75, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.